Abstract
coli or Strep, pyogenes. One inference from this could be that there are similarities in the mechanisms of tissue injury, despite the obvious differences in the structure between these organisms; Streptococci, for instance, have no endotoxin in their cell wall. We will return to this point later.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rietschel ETh, Schade U, Jensen N, Wollenweber HW, Luderitz O, Greisman SG (1982) Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis 31:8–21
Morrison DC, Ryan JL (1987) Endotoxins and disease mechanisms. Ann Rev Med 38:417–432
Le J, Vilcek J (1987) Tumor necrosis factor and interleukin 1 : cytokines with multiple overlapping biological activities. Lab Invest 56:234–248
Fong Y, Lowry SL (1990) Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 55:157–170
Waage A, Halstensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355–357
Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 319:397–400
Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A (1989) Tumour necrosis factor alpha in infectious meningitis. Arch Dis Child 64:1274–1279
Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T (1989) Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 170:1859–1867
Arditi M, Manogue KR, Caplan M, Yogev R (1990) Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 162:139–147
Debets JM, Kampmeijer R, Van der Linden MP, Buurman WA, Van der Linden CJ (1989) Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489–494
de Grotte MA, Martin MA, Densen P, Pfaller MA, Wenzel RP (1989) Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. JAMA 262:249–252
Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975–978
Offner F, Philippe J, Vogelaers D, et al. (1990) Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116:100–105
Calandra T, Baumgartner J-D, Grau GE, et al. (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161:982–987
Cannon JG, Tompkins RG, Gelfland JA, et al. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79–84
Baud L, Cadranel J, Offenstadt G, Luquel L, Guidet B, Amstutz P (1990) Tumor necrosis factor and septic shock. Crit Care Med 18:349–350
Marks JD, Marks CB, Luce JM, et al. (1990) Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methyl prednisolone administration. Am Rev Respir Dis 141:94–97
Fischer H, Dohlsten M, Andersson U, et al. (1990) Production of TNF-a and TNF-b by staphyloccal enterotoxin A activated human T cells. J Immunol 144:4663–4669
Bayston KF, Tomlinson M, Cohen J (1990) In vitro induction of tumor necrosis factor alpha by cell free supernatants from clinical isolates of Gram positive bacteria. 30th Inter-science Conf on Antimicrobial Agents and Chemotherapy, Atlanta. No. 298 (abstract)
Millar AB, Foley NM, Singer M, Johnson NMcI, Meager A, Rook GA (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712–714
Exley AR, Leese T, Cohen J (1990) Prognostic value of plasma TNF in severe acute pancreatitis. 1st Conf of Intern Endotoxin Society, San Diego
Scuderi P, Sterling KE, Lam KS, et al. (1986) Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 2:1364–1365
Grau GE, Taylor TE, Molyneux ME, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320:1586–1591
Tracey KJ, Fong Y, Hesse DG, et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662–664
Silva AT, Bayston KF, Cohen J (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor — alpha in experimental gram negative shock. J Infect Dis 162:421–427
Exley AR, Cohen J, Buurman WA, et al. (1990) Monoclonal antibody to TNF in severe septic shock. Lancet 335:1275–1277
Waxman K (1990) Pentoxifylline in septic shock. Crit Care Med 18:243–244
Strieter RM, Remick DG, Ward PA, et al. (1988) Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline. Biochem Biophys Res Commun 155:1230–1236
Smith CA, Davis T, Andreson D, et al. (1990) A receptor for tumor necrois factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Cohen, J. (1991). Clinical Role of Tumor Necrosis Factor in Septic Shock. In: Vincent, J.L. (eds) Update 1991. Update in Intensive Care and Emergency Medicine, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84423-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-84423-2_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53672-7
Online ISBN: 978-3-642-84423-2
eBook Packages: Springer Book Archive